Movatterモバイル変換


[0]ホーム

URL:


CN113755556A - One-step inactivated new coronavirus preserving fluid - Google Patents

One-step inactivated new coronavirus preserving fluid
Download PDF

Info

Publication number
CN113755556A
CN113755556ACN202111091220.6ACN202111091220ACN113755556ACN 113755556 ACN113755556 ACN 113755556ACN 202111091220 ACN202111091220 ACN 202111091220ACN 113755556 ACN113755556 ACN 113755556A
Authority
CN
China
Prior art keywords
nucleic acid
new coronavirus
solution according
inactivated
rna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202111091220.6A
Other languages
Chinese (zh)
Inventor
沈作兵
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenzhen Healthbless Biomedical Technology Co ltd
Original Assignee
Shenzhen Healthbless Biomedical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenzhen Healthbless Biomedical Technology Co ltdfiledCriticalShenzhen Healthbless Biomedical Technology Co ltd
Priority to CN202111091220.6ApriorityCriticalpatent/CN113755556A/en
Publication of CN113755556ApublicationCriticalpatent/CN113755556A/en
Pendinglegal-statusCriticalCurrent

Links

Classifications

Landscapes

Abstract

The invention discloses one-step inactivated new coronavirus preserving fluid. The formula comprises components such as a buffering agent, a chloride salt, a calcium-magnesium ion chelating agent, proteinase K, a non-ionic surfactant, a phenol red indicator, an RNase inhibitor and the like. By utilizing the combined action of the nonionic surfactant and the proteinase K, the coat protein of the new coronavirus is cracked and RNA nucleic acid is exposed in the preservation process, and further the protein combined on the RNA is also dissociated. Therefore, the preservation solution not only has the functions of inhibiting and inactivating viruses, but also omits the steps of extracting and purifying nucleic acid, can be directly adapted to the nucleic acid detection reagent of the domestic one-step method after sampling and preservation, and directly carries out quantitative detection on nucleic acid amplification without purification after the release of the nucleic acid. Effectively shortens the detection time, prevents the problem of biological infectious hazard in the waste treatment process after detection, and reduces the epidemic prevention cost.

Description

One-step inactivated new coronavirus preserving fluid
Technical Field
The invention belongs to the field of biomedicine, and particularly relates to a one-step inactivated new coronavirus preservation solution.
Background
2019 the novel coronavirus (2019-nCoV, named after the world health organization in 2020 and 1 month; SARS-CoV-2, named after the international committee for viral classification in 2020 and 2 months and 11 days) is a new strain of coronavirus which has never been found in human body before, and has high infectivity and high concealment. After people are infected with coronavirus, the common signs of the person are respiratory symptoms, fever, cough, shortness of breath, dyspnea and the like. In more severe cases, the infection can lead to pneumonia, severe acute respiratory syndrome, renal failure, and even death. At present, fluorescent quantitative PCR method is mainly adopted in all countries in the world, and gene sequencing method is rarely adopted.
Nucleic acid detection is mainly carried out by adopting a two-step method internationally: firstly, extracting and purifying nucleic acid, and then carrying out nucleic acid amplification quantitative detection.
The early sampling, conveying and storing reagent matched with the nucleic acid detection reagent of the two-step method comprises the following steps: the disposable virus sampling tube containing the non-inactivated virus preservation solution is required to have the characteristic of inactivating viruses aiming at unprotected operators and the prevention of inadvertent infectivity in the sampling, conveying and detecting processes in the later period, and a plurality of inactivated virus preservation solutions are introduced by a plurality of manufacturers in China later, wherein the inactivated virus preservation solutions utilize guanidine salt (guanidine hydrochloride or guanidine isothiocyanate) to extract nucleic acid and inactivate viruses.
Because the two-step nucleic acid detection takes up to several hours, and a user needs to be equipped with a nucleic acid extraction and purification instrument, the new positive suspicion is that a patient is difficult to investigate in time in a place with limited medical resources, and the large-scale screening speed is also influenced under the condition of urgent situation of epidemic situation, so that the epidemic prevention effect is greatly reduced. Later, many manufacturers in China creatively develop a one-step nucleic acid detection kit which does not need a nucleic acid extraction and purification instrument to perform the extraction and purification steps, and at the moment, the guanidine salt inactivation type sample storage solution originally adapted to the two-step nucleic acid detection kit cannot be adapted to the one-step nucleic acid detection reagent. In practical application, the disposable virus sampling tube containing the guanidine salt inactivated sample preserving fluid purchased by domestic medical institutions is matched with a one-step nucleic acid detection reagent, so that false negative and serious consequences of repeated detection test failure are caused in epidemic situations.
Chinese patent CN 112280823A discloses a novel coronavirus RNA sample preservation solution, the formula comprises 0.1-2 v/v% of surfactant, 1-100 mmol/L of citric acid-sodium citrate buffer solution, 0.1-5 w/v% of trehalose, 0.2-2 mol/L of betaine, 0.5-5 w/v% of sorbitol and the balance of solvent. The RNA structure can be stabilized and protected while the RNA is released by the quick splitting virus, and the integrity of the RNA can still be maintained after the RNA structure is placed at high temperature for 10 days. Can be directly used for RT-PCR amplification, each component can not inhibit the amplification process, RNA extraction is omitted, and the virus detection steps are simpler and shorter. However, the above patent formula only uses a surfactant to achieve the purpose of releasing the RNA nucleic acid of the virus sufficiently in theory, and the insufficient release of the RNA nucleic acid, especially the insufficient dissociation of the protein combined on the RNA, can easily cause the omission of the detection of the positive sample with low virus content, thereby causing serious epidemic prevention accidents. Further, there is no component which effectively inhibits RNA nuclease in the above formulation, and theoretically, the effect of inhibiting degradation of RNA nucleic acid is questionable. Therefore, RNases in the surrounding environment also cause RNA degradation during storage, which affects the RNA nucleic acid storage effect claimed in the patent.
Disclosure of Invention
Aiming at the defects in the prior art, the invention provides a one-step inactivated new coronavirus preserving fluid, which comprises the following components in the formula:
buffering agent
Chlorinated salt
Chelating agent for calcium and magnesium ions
Protease enzyme
Nonionic surfactant
Indicator agent
RNase inhibitors
Ultrapure water
Preferably, the formula of the one-step inactivated new coronavirus preservative solution comprises the following components:
buffer 0.16 wt% -0.8 wt%
Chloride salt 0.37 wt% -0.85 wt%
0.029-0.058 wt% of calcium-magnesium ion chelating agent
Protease 50ppm-100ppm
0.05 wt% -0.3 wt% of nonionic surfactant
Indicator 0.03 wt% -0.06 wt%
The RNase inhibitor concentration is 40-200U
The balance being ultrapure water
The buffer is tris-HCl buffer, PB buffer or citric acid buffer.
Preferably, the buffer is tris-HCl buffer.
The chloride salt is any one of sodium chloride and potassium chloride.
Preferably, the chloride salt is potassium chloride.
The calcium-magnesium ion chelating agent is any one of EDTA, EDTA disodium salt and EDTA tetrasodium salt.
Preferably, the calcium-magnesium ion chelating agent is EDTA.
The protease is any one of proteinase K, trypsin and pepsin.
Preferably, the protease is proteinase K.
The nonionic surfactant is any one of NP-40, tween-20 or TritonX-100.
Preferably, the nonionic surfactant is NP-40.
The indicator is any one of phenol red indicator, neutral red indicator and cresol red indicator.
Preferably, the indicator is a phenol red indicator.
The RNase inhibitor is RNase.
The buffer provides a stable pH environment for the whole new coronavirus nucleic acid; potassium chloride provides potassium ions and a proper osmotic pressure environment for subsequent nucleic acid amplification reaction; the proteinase K has activity in a wider pH range (4-12.5) and at a higher temperature (50-70 ℃), is suitable for separating RNA nucleic acid of the new coronavirus, and has the main function of enzymolysis of structural protein combined on the nucleic acid in RNA extraction so that the RNA is fully released and dissociated in a solution; NP-40 belongs to a mild nonionic surfactant, is mainly used for cracking capsid protein outside the new coronavirus to expose RNA nucleic acid of the new coronavirus, and can further dissociate protein components combined on the RNA by proteinase K so as to achieve the effect of fully exposing RNA nucleic acid monomers and greatly facilitate the quantitative amplification detection of subsequent nucleic acid. RNA nucleases exert RNA nucleic acid degradation destruction effects and must rely on divalent cations (Ca)2+With Mg2+) EDTA is used as a calcium-magnesium ion chelating agent, so that the activity of RNA nuclease can be blocked by EDTA, and the EDTA has the function of inhibiting RNA nuclease; the RNase is an effective RNase inhibitor, and the EDTA chelating agent and the RNase in the formula jointly act on the RNase to achieve the effect of deeply inhibiting the RNase, effectively prevent the RNA nucleic acid of the new coronavirus from being degraded by the RNase filled in the surrounding environment, greatly improve the storage life of the RNA nucleic acid and greatly prolong the storage time of a positive sample.
Phenol red has a pH indicating function, and is yellow when the pH of the preservation solution is lower than 7.0, which indicates that the performance of the preservation solution is reduced. Meanwhile, the operator can observe a plurality of sampling swabs in the storage tube conveniently (in order to reduce large-scale detection cost in the actual use process, one storage tube is needed to store a plurality of sampling swabs of the examinees).
The invention has the beneficial effects that: the invention relates to a one-step inactivated new coronavirus preservative fluid, which comprises the components of a buffering agent, chloride, a calcium-magnesium ion chelating agent, proteinase K, a non-ionic surfactant, a phenol red indicator, an RNA enzyme inhibitor and the like. Mainly utilizes the combined action of the nonionic surfactant and the proteinase K, and in the preservation process, the coat protein of the new coronavirus is firstly cracked, RNA nucleic acid is exposed, and further the protein combined on the RNA is also dissociated. Therefore, the preservation solution not only has the functions of inhibiting and inactivating viruses, but also omits the steps of extracting and purifying nucleic acid, can be directly adapted to the nucleic acid detection reagent of the domestic one-step method after sampling and preservation, and directly carries out quantitative detection on nucleic acid amplification without purification after the release of the nucleic acid. Effectively shortens the detection time, prevents the problem of biological infectious hazard in the waste treatment process after detection, and reduces the epidemic prevention cost.
Detailed Description
The raw materials used in the examples were as follows:
tris-HCl buffer with a purity of greater than or equal to 99%, Wuhan de sanden Biochemical technology Ltd.
EDTA, ethylenediaminetetraacetic acid, CAS number: 60-00-4, cargo number: s860021, Shandong Nu Ju Biotech Co., Ltd.
Proteinase K, 40U/mg, product number: p92303, shanghai ge to biochemistry technologies, ltd.
Phenol red indicator, CAS number: 143-74-8, Hubei Xin run chemical Co., Ltd.
RNase, 40U/. mu.L, Beijing Sorboard technologies, Inc.
Nonionic surfactant NP-40, Jinan Chengxuan chemical Co., Ltd.
Example 1
The formula of the one-step inactivated new coronavirus preservative fluid comprises the following components:
tris-HCl buffer 0.48 wt%
0.57 wt% of potassium chloride
EDTA 0.029wt%
Proteinase K75 ppm
Nonionic surfactant NP-400.15 wt%
Phenol Red indicator 0.04 wt%
RNase inhibitor concentration was 100U
The balance being ultrapure water
Example 2
The formula of the one-step inactivated new coronavirus preservative fluid comprises the following components:
tris-HCl buffer 0.48 wt%
0.57 wt% of potassium chloride
EDTA 0.029wt%
Nonionic surfactant NP-400.15 wt%
Phenol Red indicator 0.04 wt%
RNase inhibitor concentration was 100U
The balance being ultrapure water
Example 3
The formula of the one-step inactivated new coronavirus preservative fluid comprises the following components:
tris-HCl buffer 0.48 wt%
0.57 wt% of potassium chloride
EDTA0.029wt%
Proteinase K75 ppm
Phenol Red indicator 0.04 wt%
RNase inhibitor concentration was 100U
The balance being ultrapure water
Example 4
The formula of the one-step inactivated new coronavirus preservative fluid comprises the following components:
tris-HCl buffer 0.48 wt%
0.57 wt% of potassium chloride
EDTA 0.029wt%
Proteinase K75 ppm
Nonionic surfactant NP-400.15 wt%
Phenol Red indicator 0.04 wt%
The balance being ultrapure water
Example 5
The formula of the one-step inactivated new coronavirus preservative fluid comprises the following components:
tris-HCl buffer 0.48 wt%
0.57 wt% of potassium chloride
Proteinase K75 ppm
Nonionic surfactant NP-400.15 wt%
Phenol Red indicator 0.04 wt%
RNase inhibitor concentration was 100U
The balance being ultrapure water
Test example 1
And (3) respectively preserving the new coronavirus sample by using 3mL of the inactivated new coronavirus preserving fluid prepared in each embodiment, preserving at room temperature for 3 days and 7 days, respectively performing quantitative fluorescence PCR test detection, and judging the release effect of the inactivated new coronavirus preserving fluid of each embodiment on nucleic acid according to the CT value. Each example tested two different viral loads of a sample of new coronavirus: the viral load of sample a was 200 and the viral load of sample B was 100. Each sample was run in 3 replicates and the average was taken. The test results are shown in Table 1.
Table 1: test of release effect of inactivated new coronavirus preservative fluid on nucleic acid
Figure BDA0003267549820000071
The smaller the CT value in a certain range, the higher the nucleic acid content in the sample in example 1, the difference between the CT values of the sample A and the sample B is not large, the change rate of the CT value when the sample A and the sample B are stored for 3 days is also the minimum, and the comprehensive effect of the effect of releasing the nucleic acid of the formula storage solution and the stability of the stored sample nucleic acid is the optimal. Compared with example 1, the example 3 has no cleavage of the outer capsid protein of the new coronavirus by NP-40, and the CT value is higher than that of example 1; example 2 does not add proteinase K, RNA binding protein dissociation is not sufficient, so the CT value is also high, embodiment 2 and example 3 release RNA nucleic acid effect is not good. Compared with example 1, example 4 has the highest CT value without adding RNA inhibitory enzyme, and the rate of change between the CT value when stored for 7 days and the CT value when stored for 3 days is the greatest, indicating that the stability of the stored sample nucleic acid is the worst. Example 5 no EDTA was added, which also had an effect on stability.

Claims (10)

1. The one-step inactivated new coronavirus preservative fluid is characterized by comprising the following components in a formula: buffer, chloride salt, calcium-magnesium ion chelating agent, protease, nonionic surfactant, indicator, RNase inhibitor and ultrapure water.
2. The one-step inactivated new coronavirus preservative solution according to claim 1, wherein the formula comprises the following components: 0.16-0.8 wt% of buffering agent, 0.37-0.85 wt% of chloride, 0.029-0.058 wt% of calcium-magnesium ion chelating agent, 50-100 ppm of protease, 0.05-0.3 wt% of nonionic surfactant, 0.03-0.06 wt% of indicator, 40-200U of RNase inhibitor concentration and the balance of ultrapure water.
3. The one-step inactivated type preservation solution for new coronavirus according to claim 1 or 2, wherein the buffer is tris-HCl buffer, PB buffer or citric acid buffer.
4. The one-step inactivated type neocoronaviruse preservation solution according to claim 1 or 2, wherein the chloride salt is any one of sodium chloride and potassium chloride.
5. The one-step inactivated type new coronavirus preservation solution according to claim 1 or 2, wherein the calcium-magnesium ion chelating agent is any one of EDTA, disodium EDTA, and tetrasodium EDTA.
6. The one-step inactivated new coronavirus preservation solution according to claim 1 or 2, wherein the protease is any one of proteinase K, trypsin and pepsin.
7. The one-step inactivated new coronavirus preservative solution according to claim 6, wherein the protease is proteinase K.
8. The one-step inactivated coronavirus storage solution according to claim 1 or 2, wherein the nonionic surfactant is any one of NP-40, tween-20 and triton x-100.
9. The one-step inactivated new coronavirus preservation solution according to claim 1 or 2, wherein the indicator is any one of a phenol red indicator, a neutral red indicator and a cresol red indicator.
10. The one-step inactivated coronavirus storage solution according to claim 1 or 2, wherein the rnase inhibitor is RNasin.
CN202111091220.6A2021-09-172021-09-17One-step inactivated new coronavirus preserving fluidPendingCN113755556A (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
CN202111091220.6ACN113755556A (en)2021-09-172021-09-17One-step inactivated new coronavirus preserving fluid

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
CN202111091220.6ACN113755556A (en)2021-09-172021-09-17One-step inactivated new coronavirus preserving fluid

Publications (1)

Publication NumberPublication Date
CN113755556Atrue CN113755556A (en)2021-12-07

Family

ID=78796190

Family Applications (1)

Application NumberTitlePriority DateFiling Date
CN202111091220.6APendingCN113755556A (en)2021-09-172021-09-17One-step inactivated new coronavirus preserving fluid

Country Status (1)

CountryLink
CN (1)CN113755556A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
WO2022147178A1 (en)*2020-12-302022-07-07Abbott LaboratoriesImproved methods, reagents and kits for detergent-based inactivation of betacoronavirus prior to and/or while assessing a biological sample for sars-cov-2 antigen or antibody
CN116103280A (en)*2022-12-282023-05-12上海亿康医学检验所有限公司Sample preservation solution and application thereof in chromosome aneuploidy screening and/or transcriptome detection
CN116326575A (en)*2023-03-142023-06-27海孵(海南自贸区)医疗科技有限责任公司 A virus sample preservation solution and preparation method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN110982876A (en)*2020-03-042020-04-10圣湘生物科技股份有限公司Pretreatment method, pretreatment liquid, kit and application of virus nucleic acid detection
CN111304175A (en)*2020-02-152020-06-19南京尧顺禹生物科技有限公司Virus sample preservation solution for clinical detection of virus nucleic acid and use method thereof
CN111363729A (en)*2020-03-122020-07-03苏州白垩纪生物科技有限公司RNA virus inactivation preservation solution and application thereof
CN112626168A (en)*2020-12-262021-04-09杭州百迈生物股份有限公司Reagent composition for preserving virus sample and preservation method
CN112725406A (en)*2021-01-122021-04-30江苏康为世纪生物科技股份有限公司Nucleic acid extraction-free inactivated virus preservation solution and application thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN111304175A (en)*2020-02-152020-06-19南京尧顺禹生物科技有限公司Virus sample preservation solution for clinical detection of virus nucleic acid and use method thereof
CN110982876A (en)*2020-03-042020-04-10圣湘生物科技股份有限公司Pretreatment method, pretreatment liquid, kit and application of virus nucleic acid detection
CN111363729A (en)*2020-03-122020-07-03苏州白垩纪生物科技有限公司RNA virus inactivation preservation solution and application thereof
CN112626168A (en)*2020-12-262021-04-09杭州百迈生物股份有限公司Reagent composition for preserving virus sample and preservation method
CN112725406A (en)*2021-01-122021-04-30江苏康为世纪生物科技股份有限公司Nucleic acid extraction-free inactivated virus preservation solution and application thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
WO2022147178A1 (en)*2020-12-302022-07-07Abbott LaboratoriesImproved methods, reagents and kits for detergent-based inactivation of betacoronavirus prior to and/or while assessing a biological sample for sars-cov-2 antigen or antibody
CN116103280A (en)*2022-12-282023-05-12上海亿康医学检验所有限公司Sample preservation solution and application thereof in chromosome aneuploidy screening and/or transcriptome detection
CN116103280B (en)*2022-12-282024-03-15上海亿康医学检验所有限公司Sample preservation solution and application thereof in chromosome aneuploidy screening and/or transcriptome detection
CN116326575A (en)*2023-03-142023-06-27海孵(海南自贸区)医疗科技有限责任公司 A virus sample preservation solution and preparation method thereof

Similar Documents

PublicationPublication DateTitle
CN113755556A (en)One-step inactivated new coronavirus preserving fluid
Butot et al.Effects of sanitation, freezing and frozen storage on enteric viruses in berries and herbs
Wang et al.Comparison of daclatasvir resistance barriers on NS5A from hepatitis C virus genotypes 1 to 6: implications for cross-genotype activity
CN112725406B (en)Inactivated virus preservation solution free of nucleic acid extraction and application thereof
Swiss HIV Cohort Study (members listed in Acknowledgements)Residual cell-associated unspliced HIV-1 RNA in peripheral blood of patients on potent antiretroviral therapy represents intracellular transcripts
CN112779316A (en)Inactivated virus preservation solution and preparation method thereof
Borges et al.Trapping the enemy: Vermamoeba vermiformis circumvents Faustovirus mariensis dissemination by enclosing viral progeny inside cysts
CN111676216A (en)Extraction-free inactivated virus sample nucleic acid preservation solution and preparation method and application thereof
Lee et al.Characterization of severe acute respiratory syndrome coronavirus 2 stability in multiple water matrices
WO2017118718A1 (en)Modulation of accessibility of host nucleic acids to nucleic acid digesting enzymes in acellular biological fluids
CN118510910A (en) Method for processing nucleic acid containing samples
Martín et al.No evidence of selection for mutational robustness during lethal mutagenesis of lymphocytic choriomeningitis virus
KR102421648B1 (en)Method for extracting nucleic acid from sample rich in ribonuclease
CN103233005B (en)Reverse transcription-polymerase chain reaction (RT-PCR) detection kit for infectious haematopoietic necrosis viruses (IHNV) and preparation method of kit
Fletcher et al.Implications of long-term sample storage on the recovery of viruses from wastewater and biobanking
JP2023521803A (en) Product for detection of viral nucleic acid and method for detection thereof
CN105143449B (en) RNA preparation method
KR102415720B1 (en)Method for extracting nucleic acid from sample rich in polyphenol and/or polysaccharide
KR20220088974A (en)Method and kit for extracting nucleic acid from plant sample
CN113684253A (en)Inactivated preservation solution for novel coronavirus
Relova et al.Stability and integrity of classical swine fever virus RNA stored at room temperature
Alraddadi et al.Circulation of Non-Middle East Respiratory Syndrome (MERS) Coronaviruses in Imported Camels in Saudi Arabia
US20230357824A1 (en)Extraction solution for preparing a biological sample for amplification based pathogen detection
CN118360369A (en)Nucleic acid releasing agent and use method
CN117770232A (en)Cervical exfoliated cell preservation solution, preparation method and application thereof

Legal Events

DateCodeTitleDescription
PB01Publication
PB01Publication
SE01Entry into force of request for substantive examination
SE01Entry into force of request for substantive examination
RJ01Rejection of invention patent application after publication

Application publication date:20211207

RJ01Rejection of invention patent application after publication

[8]ページ先頭

©2009-2025 Movatter.jp